BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5

• Press Releases

  Naobios, Nuvonis and European Vaccine Initiative Collaborate on Manufacturing Influenza Challenge Agent

  September 2, 2025

   · 

  2 min read
• Press Releases

  Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

  September 2, 2025

   · 

  5 min read
• Press Releases

  OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors

  September 2, 2025

   · 

  5 min read
• Press Releases

  US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

  September 2, 2025

   · 

  19 min read
• Press Releases

  ICON plc to Participate at Upcoming September 2025 Investor Conferences

  September 2, 2025

   · 

  2 min read
• Press Releases

  Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting

  September 2, 2025

   · 

  2 min read
• Press Releases

  Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech’s Discovery Insights

  September 2, 2025

   · 

  4 min read
• Press Releases

  Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

  September 2, 2025

   · 

  12 min read
• Press Releases

  Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

  September 2, 2025

   · 

  7 min read
• Press Releases

  Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

  September 2, 2025

   · 

  8 min read